Search Results - Arrillaga-Romany, Isabel C

Temozolomide therapy for aggressive functioning pituitary adenomas refractory to surgery and radiation: a case series by Jordan, Justin T, Miller, Julie J, Cushing, Tucker, Seijo, Marlon, Batchelor, Tracy T, Arrillaga-Romany, Isabel C, Shih, Helen A, Nachtigall, Lisa B, Loeffler, Jay S, Dietrich, Jorg

Get full text Get full text Get full text

Modulatory Effects of Modafinil on Neural Circuits Regulating Emotion and Cognition by Rasetti, Roberta, Mattay, Venkata S, Stankevich, Beth, Skjei, Kelsey, Blasi, Giuseppe, Sambataro, Fabio, Arrillaga-Romany, Isabel C, Goldberg, Terry E, Callicott, Joseph H, Apud, José A, Weinberger, Daniel R

Get full text Get full text Get full text

Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate by Andronesi, Ovidiu C., Arrillaga-Romany, Isabel C., Ly, K. Ina, Bogner, Wolfgang, Ratai, Eva M., Reitz, Kara, Iafrate, A. John, Dietrich, Jorg, Gerstner, Elizabeth R., Chi, Andrew S., Rosen, Bruce R., Wen, Patrick Y., Cahill, Daniel P., Batchelor, Tracy T.

Get full text Get full text Get full text

Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma by Alexander, Brian M., Trippa, Lorenzo, Gaffey, Sarah, Arrillaga-Romany, Isabel C., Lee, Eudocia Q., Rinne, Mikael L., Ahluwalia, Manmeet S., Colman, Howard, Fell, Geoffrey, Galanis, Evanthia, de Groot, John, Drappatz, Jan, Lassman, Andrew B., Meredith, David M., Nabors, L. Burt, Santagata, Sandro, Schiff, David, Welch, Mary R., Ligon, Keith L., Wen, Patrick Y.

Get full text Get full text Get full text

Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas by Brastianos, Priscilla K., Kim, Albert E., Giobbie-Hurder, Anita, Lee, Eudocia Quant, Wang, Nancy, Eichler, April F., Chukwueke, Ugonma, Forst, Deborah A., Arrillaga-Romany, Isabel C., Dietrich, Jorg, Corbin, Zachary, Moliterno, Jennifer, Baehring, Joachim, White, Michael, Lou, Kevin W., Larson, Juliana, de Sauvage, Magali A., Evancic, Kathryn, Mora, Joana, Nayyar, Naema, Loeffler, Jay, Oh, Kevin, Shih, Helen A., Curry, William T., Cahill, Daniel P., Barker, Fred G., Gerstner, Elizabeth R., Santagata, Sandro

Get full text Get full text Get full text

Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent Glioblastoma by Chi, Andrew S., Cahill, Daniel P., Reardon, David A., Wen, Patrick Y., Mikkelsen, Tom, Peereboom, David M., Wong, Eric T., Gerstner, Elizabeth R., Dietrich, Jorg, Plotkin, Scott R., Norden, Andrew D., Lee, Eudocia Q., Nayak, Lakshmi, Tanaka, Shota, Wakimoto, Hiroaki, Lelic, Nina, Koerner, Mara V., Klofas, Lindsay K., Bertalan, Mia S., Arrillaga-Romany, Isabel C., Betensky, Rebecca A., Curry, William T., Borger, Darrel R., Balaj, Leonora, Kitchen, Robert R., Chakrabortty, Sudipto K., Valentino, Michael D., Skog, Johan, Breakefield, Xandra O., Iafrate, A. John, Batchelor, Tracy T.

Get full text Get full text Get full text

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma by Cloughesy, Timothy F., Mochizuki, Aaron Y., Orpilla, Joey R., Hugo, Willy, Lee, Alexander H., Davidson, Tom B., Wang, Anthony C., Ellingson, Benjamin M., Rytlewski, Julie A., Sanders, Catherine M., Kawaguchi, Eric S., Du, Lin, Li, Gang, Yong, William H., Gaffey, Sarah C., Cohen, Adam L., Mellinghoff, Ingo K., Lee, Eudocia Q., Reardon, David A., O’Brien, Barbara J., Butowski, Nicholas A., Nghiemphu, Phioanh L., Clarke, Jennifer L., Arrillaga-Romany, Isabel C., Colman, Howard, Kaley, Thomas J., de Groot, John F., Liau, Linda M., Wen, Patrick Y., Prins, Robert M.

Get full text Get full text Get full text